Pelthos Therapeutics Inc.
4 private offerings reported to the SEC on Form D since 2016, $76.3M sold in all. Pharma, North Carolina.
- Form D offerings: 4
- Reported sold: $76.3M
- Newest: Nov 16, 2026
- IPO: Feb 20, 2024 · $6.6M
- FDA records: Company page
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Nov 16, 2026 | — | $57.5M | $57.5M | Pelthos Therapeutics Inc.Pharma · North Carolina | Not amended | 0001919246-26-000142 |
| Nov 19, 2025 | — | $18.0M | $18.0M | Pelthos Therapeutics Inc.Pharma · North Carolina | Not amended | 0001919246-25-000006 |
| Aug 6, 2024 | — | $750K | $750K | Chromocell Therapeutics CorpPharma · New Jersey | Not amended | 0001919246-24-000001 |
| Aug 6, 2024 | — | None yet | $30.0M | Chromocell Therapeutics CorpPharma · New Jersey | Not amended | 0001919246-24-000002 |
- Ticker
- PTHS
- Business address
- Durham, NC
- Incorporated in
- Nevada
- SEC industry
- Biological Products, (No Diagnostic Substances)
- Former names
- Channel Therapeutics Corp; Chromocell Therapeutics Corp
- All SEC filings
- CIK 1919246 on EDGAR
- FDA records
- Approvals, clearances, recalls and letters
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR